Public Health
-
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado…
Read More » -
Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for…
Read More » -
Pfizer weight loss pill joins list of obesity drug flops
Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a…
Read More » -
Pfizer to discontinue twice-daily version of weight loss pill
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients…
Read More » -
Biden’s Got a New Set of Orders for Obamacare. Is It His Last?
The Biden administration has issued its latest official wish list for Obamacare insurance plans, potentially one of the last major…
Read More » -
Explosive DeSantis-Newsom Debate Reflects Nation’s Culture Wars
Fox News officially titled it “The Great Red vs. Blue State Debate.” But the faceoff quickly turned into a full-out…
Read More » -
‘Forever Chemicals’ Found in Freshwater Fish, Yet Most States Don’t Warn Residents
Bill Eisenman has always fished. “Growing up, we ate whatever we caught — catfish, carp, freshwater drum,” he said. “That…
Read More » -
Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes
A 0.25 mg injection pen of Novo Nordisk’s weight loss drug Wegovy is shown in this photo in Oslo, Norway,…
Read More » -
El daño colateral de la crisis de Medicaid: miles están perdiendo beneficios de alimentos
Una hora antes del amanecer, Shelly Brost caminó una milla bajo la lluvia helada hasta la oficina de asistencia pública…
Read More » -
Adultos mayores, detectives contra avisos engañosos de Medicare Advantage
Después de una ofensiva sin precedentes contra las publicidades engañosas de las aseguradoras que venden planes privados de Medicare Advantage…
Read More »